BacMam-mediated gene delivery into multipotent mesenchymal stromal cells
Michael O'Grady1, Robert H Batchelor, Kelly Scheyhing
1Primary and Stem Cell Systems, Life Technologies, Carlsbad, CA, USA.
Methods in Molecular Biology (Clifton, N.J.)
|March 25, 2011
Summary
BacMam viruses, a modified baculovirus, efficiently deliver genes into hard-to-transfect cells like stem cells. This technology enables high-level protein production and gene expression, ideal for cell-based assays and therapeutic development.
Area of Science:
- Biotechnology
- Molecular Biology
- Virology
Background:
- Baculoviruses are established tools for high-level protein production in insect cells.
- Modified baculoviruses (BacMam) utilize mammalian promoters for efficient gene delivery into mammalian cells.
- BacMam transduction demonstrates high efficiency with minimal cellular damage across various cell types, including stem cells.
Purpose of the Study:
- To describe methods for generating high-titer BacMam stocks.
- To highlight BacMam's utility for transducing mesenchymal stem cells (MSCs) and their derivatives.
- To showcase BacMam as an effective gene delivery system for challenging cell types.
Main Methods:
- Construction of BacMam viruses using shuttle vectors capable of carrying large gene fragments (up to 38 kb).
- Generation of high-titer BacMam stocks for efficient transduction.
- Application of BacMam for delivering fluorescent protein markers, small interfering RNA (siRNA), and in cell-based assays.
Main Results:
- BacMam viruses achieve high transduction efficiencies in various cell types, including primary and adult stem cells.
- The system supports the delivery and expression of large genes and multiple genes simultaneously.
- Minimal cytopathic effects are observed, preserving cell viability and function.
Conclusions:
- BacMam technology provides an efficient and versatile method for gene delivery and expression in difficult-to-transfect cells.
- This approach is particularly valuable for stem cell research and the development of cell-based therapeutics.
- High-titer BacMam stock generation is crucial for successful transduction of MSCs and their derivatives.


